| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 5 495-503, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
T Kameda, H Watanabe and H Iba
Department of Gene Regulation, University of Tokyo, Japan.
To analyze the function of AP-1 in cartilage formation, two types of primary chondrocytes, LS and US cells, were prepared from caudal (lower) and cephalic (upper) regions of chicken sterna, respectively. All the known components of chicken AP-1 (c-Fos, Fra-2, c-Jun, and JunD) were detected in both cell types, but the expression level of c-Jun was much higher in LS cells, which are rich in less mature chondrocytes than US cells. In the sterna, the expression level of c-Jun was also lower in the maturating or hypertropic chondrocytes than in proliferating chondrocytes. When US cells were treated with parathyroid hormone (PTH), which prevented maturation as judged from the maturation-associated markers such as alkaline phosphatase and type X collagen, the expression levels of c-Jun and JunD were constitutively elevated. To analyze the possible relationship between differentiation status and expression levels of Jun family proteins, they were exogenously introduced into the entire population of US cells within 2 days by using high titer, replication-competent retroviral vectors. Maturation-associated markers in US cells were specifically lowered by exogenous expression of c-Jun or JunD to similar levels to those of LS cells or US cells treated with PTH. When US cells were infected with the virus encoding a dominant negative mutant of AP-1 (supJunD-1), maturation markers were moderately increased 10 days after infection. The potent induction of alkaline phosphatase activity in US cells by all-trans retinoic acid was annulled by exogenous expression of either c-Jun or JunD. These results suggest that Jun family proteins negatively regulate the maturation process of chondrocytes.
This article has been cited by other articles:
![]() |
S.-G. Hwang, S.-S. Yu, H. Poo, and J.-S. Chun c-Jun/Activator Protein-1 Mediates Interleukin-1{beta}-induced Dedifferentiation but Not Cyclooxygenase-2 Expression in Articular Chondrocytes J. Biol. Chem., August 19, 2005; 280(33): 29780 - 29787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hess, B. Hartenstein, S. Teurich, D. Schmidt, M. Schorpp-Kistner, and P. Angel Defective endochondral ossification in mice with strongly compromised expression of JunB J. Cell Sci., November 15, 2003; 116(22): 4587 - 4596. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg, and A. Yayon Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations J. Cell Sci., January 2, 2002; 115(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwamoto, Y. Higuchi, E. Koyama, M. Enomoto-Iwamoto, K. Kurisu, H. Yeh, W. R. Abrams, J. Rosenbloom, and M. Pacifici Transcription Factor Erg Variants and Functional Diversification of Chondrocytes during Limb Long Bone Development J. Cell Biol., July 10, 2000; 150(1): 27 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Thomas, A Sunters, A Gentry, and A. Grigoriadis Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene J. Cell Sci., January 2, 2000; 113(3): 439 - 450. [Abstract] [PDF] |
||||
![]() |
M. Murakami, M. Ui, and H. Iba Fra-2-positive Autoregulatory Loop Triggered by Mitogen-activated Protein Kinase (MAPK) and Fra-2 Phosphorylation Sites by MAPK Cell Growth Differ., May 1, 1999; 10(5): 333 - 342. [Abstract] [Full Text] |
||||
![]() |
A. M. Ionescu, E. M. Schwarz, C. Vinson, J. E. Puzas, R. Rosier, P. R. Reynolds, and R. J. O'Keefe PTHrP Modulates Chondrocyte Differentiation through AP-1 and CREB Signaling J. Biol. Chem., April 6, 2001; 276(15): 11639 - 11647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |